Liquid biopsy has emerged as a groundbreaking technique in the early detection, diagnosis, and monitoring of various cancers. This non-invasive method uses blood samples to analyze tumor-related genetic material, such as circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. Liquid biopsy offers a range of advantages over traditional tissue biopsies, including lower risk, faster results, and the ability to monitor disease progression and therapeutic efficacy in real time.
Comments
0 comment